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Wednesday, February 11, 2015 573aelectron microscopy (EM) and super-resolution microscopy (gSTED, STORM)
and used optical mapping and computer modeling to investigate the implica-
tions for ephaptic conduction in the heart. gSTED and STORM revealed
Nav1.5 and b1 enrichment within ID regions not containing dense clusters of
Cx43 and N-Cadherin. Notably, both were identified within the perinexus, a mi-
crodomain surrounding Cx43 gap junctions. Overall, 22% of Nav1.5 was
located within perinexal regions while only 2% was within Cx43 clusters.
EM revealed closer membrane apposition at perinexal (<10nm) vs. non-
perinexal intercalated disk sites (>10nm) under control conditions. AIE
increased intermembrane distance at perinexal, but not at non-perinexal sites.
Functionally, this correlated with decreased transverse conduction velocity
(CV-T; 15.250.3 vs. 19.650.1cm/s) and increased anisotropic ratio (AR;
3.050.2 vs. 2.850.1) relative to control, in perfused guinea pig ventricles.
Next, we investigated AIE effects on Nav1.5 function in conduction. Nav1.5
blockade (0.5 mM flecainide) by itself decreased CV (18%) without changing
AR. However, Nav1.5 inhibition during AIE preferentially decreased CV-T
(13.050.6cm/s), increased AR (3.350.2) and increased spontaneous arrhyth-
mias (7/9 vs. 4/11) compared to AIE alone. Notably, only a computer model
including ephaptic coupling and the ID localization of Nav1.5 could recapitu-
late these results. In summary, sodium channel complexes localized to ID mi-
crodomains such as the perinexus may enable ephaptic conduction in the heart.
Further, Nav1.5 functional availability and perinexal membrane spacing
emerge as novel determinants of anisotropic conduction.
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Sodium channel mutations near the IQ and EFL motifs in the carboxyterminal
(CT) domain have been linked to long QT (LQTS) and Brugada syndromes
(BrS). IQ-calmodulin (CaM) interaction is important for regulation of cardiac
Na channels. The aim of this study was to assess the role of Naþ–Ca2þ/CaM
signaling via IQ motif of the Naþ channels in development and maturation
of intercalated disc (ID). We studied transgenic mice with alanines knocked
into IQ positions in the Nav1.5 CT. The homozygous mice are embryonic lethal
and heterozygous mice (IQ/AAþ/ mice), develop cardiomyopathy (DCM).
We measured the signal and distribution of Nav1.5, syntrophin, Cx43 and rya-
nodine in 3 and 9 month old IQ/AAþ/ mice. Results were compared to those
obtained from age matched wild type mice. By immunohistochemistry we
show that Nav1.5 protein in 9 month-old IQ/AA
þ/ mice is significantly
reduced at the ID. Syntrophin that traffics Na channels to the membrane, is
not altered. Cx43 which is co-located with Nav1.5 at the ID, is significantly
reduced. The expression of these proteins were not altered in 3 month-old
IQ/AAþ/ mice. We also assessed the implication of IQ domain on the local-
ization of Ca2þ handling protein such as ryanodine receptor and found that it
was significantly altered in 9 month-old IQ/AAþ/ mice. The data suggest
that enhanced late INa,L in IQ/AA
þ/ mice contributes to DCM via remodeling
of electrical and junctional proteins and demonstrate a dynamic interplay of
Naþ–Ca2þ/CaM signaling via IQ motif of the Naþ channels in ID development
and maturation. Our study highlights the importance of Ca2þ/CaM-mediated
regulation of Naþ channels in DCM and arrhythmia.
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Long QT type 3 (LQT3) is caused by mutations that cause an increase in the
cardiac sodium current during late phases of the cardiac action potential. For
a number of LQT3 mutants this is caused by a failure to inactivate fully, and
a consequent increase in late sodium current. For several mutations, shifts in
voltage dependence of activation and inactivation cause increased sodium
channel contribution to more depolarized voltages, an effect referred as in-
crease in window current. The goal of this study was to perform a study in a
large number of LQT3 associated mutations and compare the biophysical effect
of the mutation to cardiac risk in LQT3 patients and response to treatment. We
measured the function of eight common mutations associated with LQT3 with
different mechanism underlying channel dysfunction. We compared the func-
tional effects of the channel with the clinical course of these patients andobserved that for the two mutations tested with increased sustained current
but without increase in current availability (window current), D1784K and
D1790G, the patients had significant lower risk of cardiac events, suggesting
an increase in current availability may be associated with increased risk for
these patients. In addition, we measured mutation specific effects of ranolazine
for these mutants. For all mutants tested, ranolazine preferentially blocked late
sodium currents. Ranolazine shifts steady-state availability of the inactivation
was dependent on the specific mutant tested. Our results suggest that ranolazine
may have a mutation dependent effect. Mutations dysfunction may affect drug
binding and drug actions in the channel and may alter treatment effectiveness in
patients.
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Pyrethroid insecticides target voltage-gated sodium channels. Emerging
mosquito resistance to widely used pyrethroids demands development of
new insecticides. Earlier the X-ray structure of the open Kv1.2 channel and
mutagenesis data were used to build two homology models of insect sodium
channels with pyrethroid receptors PyR1 (O’Reilly et al., 2006) and PyR2
(Du et al., 2013) located, respectively, in the II/III and I/II domain interfaces.
The models differ in the number of contributing transmembrane helices,
orientation of the bound pyrethroid molecules, and the depth of their penetra-
tion in respective domain interfaces. Here we employed our PyR2 model to
elaborate an analogous PyR1 model. Computational docking yielded a revised
PyR1 model with deltamethrin bound between the linker helix IIS4-S5 and
transmembrane helices IIS5, IIS6 and IIIS6 with its dibromoethenyl and
diphenylether moieties oriented, respectively, in the intra- and extracellular
directions. Comparison of the PyR2 and revised PyR1 models predicted
new deltamethrin-channel contacts. Model-driven mutagenesis followed by
electrophysiological measurements unveiled two new pyrethroid-sensing res-
idues in PyR1 and four such residues in PyR2. Taken together, the new and
previously published data support the following conclusions. (i) PyR1 is
formed by helices IIS4-S5, IIS5, IIS6, and IIIS6. PyR2 is formed by helices
IS4-S5, IS5, IS6, and IIS6. (ii) Helix IIS6 contains four residues that
contribute to PyR1 and four residues that contribute to PyR2. (iii) Seven pairs
of pyrethroid-sensing residues are located in analogous positions of domain
interfaces I/II and II/III indicating rotational symmetry of the two pyrethroid
receptor sites. (iv) Pyrethroids bind to both sites in similar orientations,
deeply penetrating in the respective domain interfaces. Our study elaborates
the dual pyrethroid-receptor sites model and provides a structural background
for rational development of new pyrethroid insecticides. Supported by NIH
and NSERC.
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Voltage-gated sodium channel (Nav) inhibitors are used clinically as analgesics
and local anesthetics. However, the absence of Nav channel isoform selectivity
of current treatment options can result in adverse cardiac and CNS side effects,
limiting their therapeutic utility. Human hereditary gain- or loss-of-pain
disorders have demonstrated an essential role of Nav1.7 sodium channels in
the sensation of pain, thus making this channel an attractive target for new
pain therapies. We have identified a novel, human Nav1.7 selective inhibitor
(PF-05089771, IC50¼ 11 nM) that preferentially interacts with, and stabilizes,
inactivated conformation(s) of the channel via an interaction with the voltage-
sensor domain (VSD) of Domain 4. The current study demonstrates that
PF-05089771 exhibits concentration-dependent slowly developing inhibition
(tau ¼ 209 sec and 33 sec, at 100 nM and 1 mM, respectively), and a similarly
slow recovery from block upon washout (tau ~7 min). PF-05089771 exhibits
minimal use-dependent inhibition until concentrations exceed 10-fold the
IC50, which is consistent with the observed slow onset of block and/or a low
affinity for resting or fast-inactivated channel conformations. To evaluate
this further, we employed whole cell patch clamp protocols to separate
channels into predominantly fast- or slow-inactivated Nav populations. Inhi-
bition by PF-05089771 develops with similar rates using protocols that biases
for either fast- or slow-inactivated states, suggesting that preference for a
particular inactivated state (fast, intermediate or slow) appears less critical
than the relative time that the channel is in an inactivated state during
574a Wednesday, February 11, 2015compound exposure. The inhibition profile of PF-05089771 suggests that a
conformational change in the Domain 4 VSD couples to multiple downstream
inactivated states and immobilizing the voltage-sensor via a small molecule
interaction with this site may lock the channel into long term inactivation
from which recovery is slow.
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Mutations in voltage-gated sodium (Nav) channel isoforms are correlated with
a wide range of cardiovascular and neurological diseases in humans, and are
therefore are important targets for the rational design of novel drugs. The
cardiac isoform of the Nav channel, Nav1.5, presents a unique target for the
development of antiarrhythmic drugs. In this work, we identify key structural
motifs for local anesthetic binding in the pore-domain of the open and closed
states of the human Nav1.5 channel. The Rosetta structural modeling method
was used to construct models of human Nav1.5 isoform based on the 3D crystal
structures of bacterial Nav channels: NavRh (closed state) and NavMs (open
state). The resulting lowest free-energy models were selected for local anes-
thetic docking simulations. Rosetta loop modeling and global relaxation of
10,000 models yielded a convergent motif in the selectivity filter region of a
stabilizing hydrogen bond network between Tryptophan and Threonine pairs.
A membrane-facing fenestration near the S6 helix of domain IV and the S5 he-
lix of domain III was also structurally conserved, and is a proposed site of
neutral drug entry. Docking simulations of the channel blocker, lidocaine,
reveal key protein-ligand binding configurations within the pore. Our prelimi-
nary models of the human Nav1.5 channel in the open and closed states reveal
highly conserved structural motifs important for both stabilization of the pore
domain, as well as for drug entry and binding. Future work will use structural
models of drug interaction with human Nav1.5 as a dynamic testing platform
for the calculation of the kinetics of drug binding and unbinding.
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Voltage gated sodium (Nav) channels are responsible for initiation and propa-
gation of action potentials in nerve and muscle. Due to their physiological roles,
Nav channels are prime targets of natural toxins from a variety of organisms
such as spiders, scorpions, snakes and cone snails. ProTx-II, from the tarantula
Thrixopelma prurient, is a 30-residue peptide toxin that is a potent inhibitor of
Nav channels. It binds to voltage sensor domains (VSDs) II and IV of human
Nav1.7 channels. It is more than 100-fold selective for Nav1.7 versus all other
human Nav channel isoforms. Magi-5, from Macrothele gigas, is a 29-residue
peptide toxin that stabilizes an activated state of the domain II VSD of Nav
channels. Both spider toxins share a structural fold stabilized by the same disul-
fide bridge network, yet they have opposite effects on Nav function: ProTx-II
stabilizes a resting state of VSDII, while Magi-5 stabilizes an activated state.
We use solid phase peptide synthesis to generate ProTx-II - Magi-5 chimeras
by inserting loop regions between conserved cystines of Magi-5 into ProTx-
II. Molecular modeling, protein-protein docking and electrophysiology tech-
niques are used to identify critical residues responsible for opposite effects
of ProTx-II and Magi-5 on Nav channel function. Our findings may be useful
in the design of novel modulators of human Nav1.7 channel and may elucidate
important structural determinants of VSD toxin activity.
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Fibroblast growth factor 14 (FGF14) is a functionally relevant accessory protein
of the neuronal Nav channel. Through a monomeric interaction with the intra-
cellular C-terminus of neuronal Nav channels, FGF14 modulates Naþ currents
in a Nav isoform-specific manner serving as a fine-tuning regulator of excit-
ability. In previous studies we have reconstituted the PPI interaction of
FGF14 andNav1.6 in live cells using the split-luciferase complementation assay(LCA) and through site-direct mutagenesis identified ‘‘hot-spots’’ at the FGF14
surface critical for binding to Nav1.6. Based on the FGF14 monomer structure
generated in silico, we have designed short peptide fragments that align with
pockets defined by the FGF14 b12-strand and b8-b9 loop and validated their
in-cell activity as inhibitors of the FGF14:Nav1.6 complex. We then applied
patch-clamp electrophysiology and show exciting preliminary data indicating
that two peptides, Fpep1 and Epep1, exhibit either a negative allosteric modu-
lators (NAM)-like or a positive allosteric modulators (PAM)-like activity
against Nav1.6-encoded currents. For one peptide, Fpep1, we have begun me-
dicinal chemistry efforts to generate novel peptidomimetics that are currently
being evaluated. These breakthrough results identify the FGF14 b8-b9 and
b12 as part of potential druggable pockets against the FGF14-Nav1.6 complex
and indicate that small molecule inhibitors (SMI) and/or peptidomimetics
targeting these pockets might give rise to a new class of unconventional PPI-
based allosteric modulators of Nav channels that could restore dysfunction of
neuronal excitability and plasticity in brain disorders. These results provide
fundamental new knowledge for the design of new leads targeting the Nav chan-
nel macromolecular complex. We expect our studies to have a broad impact in
the drug design against a wide range of still untreatable brain disorders
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Voltage-gated sodium channels play essential roles in electrical signaling in the
nervous system and are key pharmacological targets. We have carried out
multi-microsecond Anton simulations of the bacterial NavAb channel to reveal
ion conduction intimately connected with conformational fluctuations of the
protein pore (C Boiteux, I Vorobyov & TW Allen, 2014 PNAS 111:3454),
and a multiple-ion mechanism underlying Naþ versus Kþ selectivity. We
observe collapse of the pore domain, involving residues identified in pore-
based slow inactivation and drug binding in prokaryotic and eukaryotic chan-
nels. We demonstrate high affinity binding of anti-epileptic and local anesthetic
drugs to F203, that is a surrogate for the highly conserved FS6 in mammalian
sodium channels, as well as low affinity sites with potential roles in channel
inhibition. We observe two drug access pathways, including a previously
suggested lipophilic route via membrane-bound fenestrations, and an aqueous
pathway through the channel pore, despite being closed (C Boiteux, et al. 2014
PNAS 111:13057). These studies provide new insight into Nav function and
modulation, and predictions to assist future drug development.
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Although extensive electrophysiological characterization is available for eu-
karyotic voltage-gated Naþ channels (Nav), no high-resolution structures of
these channels are available. Crystal structures of several bacterial Nav chan-
nels have been published and molecular dynamics simulations of ion perme-
ation through these channels are consistent with many electrophysiological
properties of the eukaryotic channels. Unlike eukaryotic Nav channels, howev-
er, the bacterial Nav channels are strongly outwardly rectifying, and the mech-
anism of this rectification has not previously been described. We used step-wise
pulling protocols to implement Jarzynski’s Equality in non-equilibrium molec-
ular dynamics simulations of ion permeation through the bacterial NavAb
channel to obtain a mechanistic description of this outward rectification.
Results of the simulations indicate that two or three extracellular Kþ ions
bind tightly at the same z-coordinate along the selectivity filter of NavAb
and can effectively block the channel in the presence of modest voltages or con-
centration driving forces. The configuration with two potassium ions located at
the same z-coordinate is also found in the two-dimensional potential of mean
forces generated from umbrella sampling and weighted histogram analysis.
In contrast to Kþ, three Naþ ions move through the selectivity filter together
